Narayana Hrudayalaya Limited (NH)

Name: Narayana Hrudayalaya Limited (NH) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Healthcare · Wall Street (EE. UU.) · Última actualización: 2026-09-20

Narayana Hrudayalaya Limited provides medical and healthcare services in India, the United Kingdom, and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments.

Cifras clave

Capitalización bursátil: ₹392 billion
Ingresos (ejercicio cerrado en 2026-03-31): ₹78.6B
Beneficio neto: ₹8.1B
Margen bruto: 55.9%
Margen neto: 10.3%

Ver gráficos interactivos y estados completos →

Cuenta de resultados anual

Cuenta de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Ingresos totales	₹78.6B	₹54.6B	₹48.8B	₹44.9B
Beneficio bruto	₹44.0B	₹27.7B	₹24.4B	₹21.6B
Ingresos operativos (EBIT)	₹12.1B	₹10.3B	₹9.4B	₹7.9B
Ingresos netos	₹8.1B	₹7.9B	₹7.9B	₹6.1B

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de NH. /companies/us/NH

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.